| Status: Excluded due to NICE appraisal | |
Product meets AWMSG exclusion criteria due to NICE appraisal TA942: Empagliflozin for treating chronic kidney disease |
|
Medicine details |
|
| Medicine name | empagliflozin (Jardiance®) |
| Formulation | oral |
| Reference number | 3570 |
| Indication | Treatment of chronic kidney disease in patients with or without type 2 diabetes |
| Company | Boehringer Ingelheim Ltd |
| BNF chapter | Endocrine system |
| Assessment type | N/A |
| Status | Excluded due to NICE appraisal |
| Date of issue | 24/03/2023 |
| NICE guidance | |